Hester Biosciences outlines continued growth in Poultry and AH segments, with potential repurposing of the BSL-3 facility to enhance veterinary vaccine capacity; management remains focused on sustaining EBITDA growth and market momentum.
AI Assistant
Hester Biosciences Ltd
2026
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.